ISSN: 1757-6180
Journal Home
Journal Guideline
Bioanalysis Q2 Unclaimed
Bioanalysis is a journal indexed in SJR in Medicine (miscellaneous) and Analytical Chemistry with an H index of 67. It has an SJR impact factor of 0,462 and it has a best quartile of Q2. It has an SJR impact factor of 0,462.
Bioanalysis focuses its scope in these topics and keywords: biological, msms, method, bioanalysis, quantitation, developmentstwostep, derivatization, doping, dried, drugs, ...
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,462
SJR Impact factor67
H Index118
Total Docs (Last Year)532
Total Docs (3 years)3469
Total Refs900
Total Cites (3 years)469
Citable Docs (3 years)1.55
Cites/Doc (2 years)29.4
Ref/DocOther journals with similar parameters
Seizure : the journal of the British Epilepsy Association Q2
Genes to Cells Q2
Acta Neurologica Scandinavica Q2
Clinical Rheumatology Q2
Annals of Global Health Q2
Compare this journals
Aims and Scope
Best articles by citations
Proteomics of drug-resistant cancer biomarkers
View moreThe 5th Annual Shanghai Symposium on Clinical & Pharmaceutical Solutions through Analysis
View moreRecent advances in hydrophilic interaction chromatography for quantitative analysis of endogenous and pharmaceutical compounds in plasma samples
View moreQuantitative immunocapture MS: current status and challenges in drug discovery
View moreUntargeted profiling of urinary steroid metabolites after testosterone ingestion: opening new perspectives for antidoping testing
View moreBreath analysis of ammonia, volatile organic compounds and deuterated water vapor in chronic kidney disease and during dialysis
View moreAn ultra-sensitive clinical biomarker assay: quantitation of thymus and activation-regulated chemokine in human plasma
View moreMetabolomics of drugs of abuse: a more realistic view of the toxicological complexity
View moreA screening UHPLC-MS/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical species
View more7th GCC Insights: incurred samples use; fit-for-purpose validation, solution stability, electronic laboratory notebook and hyperlipidemic matrix testing
View moreHair: a complementary source of bioanalytical information in forensic toxicology
View moreForensic and clinical toxicology
View moreNonclinical immunogenicity risk assessment of therapeutic proteins
View moreLabel-free MS imaging from drug discovery to preclinical development
View moreA multiplexed hybrid LC-MS/MS pharmacokinetic assay to measure two co-administered monoclonal antibodies in a clinical study
View morePaper spray-MS for bioanalysis
View moreRecent advances in MS methods for nicotine and metabolite analysis in human matrices: clinical perspectives
View moreDetermination of eniluracil and 5-fluorouracil in human plasma by LC-MS/MS
View moreMatrix effect and recovery terminology issues in regulated drug bioanalysis
View moreAn optimal LC-MS/MS method for determination of azithromycin in white blood cells: application to pediatric samples
View moreMethods for urine drug testing using one-step dilution and direct injection in combination with LC-MS/MS and LC-HRMS
View moreFeedback from the European Bioanalysis Forum Workshop: taking tiered approach to the next level
View moreReducing pre-clinical blood volumes for toxicokinetics: toxicologists, pathologists and bioanalysts unite
View more2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 1 -small molecules by LCMS)
View more
Comments